Shehnaaz Suliman
Director/Board Member chez ULTRAGENYX PHARMACEUTICAL INC.
Fortune : 866 593 $ au 31/03/2024
Profil
Shehnaaz Suliman is currently the Chief Executive Officer & Director at ReCode Therapeutics, Inc. She also serves as the Chairman at Executive Women in Bio.
In addition, she holds positions as an Independent Director at Ultragenyx Pharmaceutical, Inc. and 10X Genomics, Inc. Previously, she worked as a Director at Parvus Therapeutics, Inc. from 2017 to 2019.
Prior to that, she was the Vice President & Head-Global Therapeutic at Roche Holding AG from 2015 to 2017.
She also served as the Senior VP-Corporate Development & Strategy at Theravance Biopharma, Inc. from 2017 to 2019.
From 2021 to 2022, she was the Chief Operating & Business Officer at Alector, Inc. Dr. Suliman obtained a graduate degree and an MBA from the University of Oxford.
She also holds an undergraduate degree and a doctorate from the University of Cape Town.
Additionally, she earned an MBA from Saïd Business School.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 07/06/2023 | 14 855 ( 0,02% ) | 693 580 $ | 31/03/2024 | |
10X GENOMICS INC CLASS A
0,00% | 14/06/2023 | 4 610 ( 0,00% ) | 173 013 $ | 31/03/2024 |
Postes actifs de Shehnaaz Suliman
| Sociétés | Poste | Début |
|---|---|---|
| ULTRAGENYX PHARMACEUTICAL INC. | Director/Board Member | 30/01/2019 |
| 10X GENOMICS, INC. | Director/Board Member | 01/08/2019 |
Executive Women in Bio
 Executive Women in Bio Miscellaneous Commercial ServicesCommercial Services Executive Women in Bio provides mentoring program services to support women in various stages of career and personal development. | Chairman | - |
ReCode Therapeutics, Inc.
 ReCode Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology ReCode Therapeutics, Inc. operates as a biopharmaceutical company. It develops precision medicines for pulmonary diseases. The company is headquartered in Irvin, TX. | Chief Executive Officer | 11/01/2022 |
Anciens postes connus de Shehnaaz Suliman
| Sociétés | Poste | Fin |
|---|---|---|
| ALECTOR, INC. | Chief Executive Officer | 15/12/2021 |
Parvus Therapeutics, Inc.
 Parvus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Parvus Therapeutics, Inc. manufactures and sells biopharmaceutical products. The private company is based in Calgary, Canada. | Director/Board Member | 01/07/2019 |
| THERAVANCE BIOPHARMA, INC. | Corporate Officer/Principal | 31/03/2019 |
| ROCHE HOLDING AG | Corporate Officer/Principal | 01/07/2017 |
Formation de Shehnaaz Suliman
| University of Oxford | Graduate Degree |
| University of Cape Town | Doctorate Degree |
| Saïd Business School | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 5 |
|---|---|
| ROCHE HOLDING AG | Health Technology |
| ULTRAGENYX PHARMACEUTICAL INC. | Health Technology |
| 10X GENOMICS, INC. | Health Technology |
| THERAVANCE BIOPHARMA, INC. | Health Technology |
| ALECTOR, INC. | Health Technology |
| Entreprise privées | 3 |
|---|---|
ReCode Therapeutics, Inc.
ReCode Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology ReCode Therapeutics, Inc. operates as a biopharmaceutical company. It develops precision medicines for pulmonary diseases. The company is headquartered in Irvin, TX. | Health Technology |
Parvus Therapeutics, Inc.
Parvus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Parvus Therapeutics, Inc. manufactures and sells biopharmaceutical products. The private company is based in Calgary, Canada. | Health Technology |
Executive Women in Bio
Executive Women in Bio Miscellaneous Commercial ServicesCommercial Services Executive Women in Bio provides mentoring program services to support women in various stages of career and personal development. | Commercial Services |
